KENILWORTH, N.J. & NEW YORK–(BUSINESS WIRE) December 22, 2017 –Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Pfizer Inc. (NYSE:PFE), today announced that the U.S. Food and Drug Administration (FDA) has approved…Original Article
FDA Approves Segluromet (ertugliflozin and metformin hydrochloride) for Type 2 Diabetes
